According to the National Health and Medical Research Council – NHMRC clinical trials across Australia are in the following categories:
– treatment trials to test new treatments, new medicines or combinations of medicines; or other new therapies such as surgery, the use of new medical devices or new approaches to surgery
– diagnostic or screening trials to evaluate tests or procedures to diagnose and detect diseases or conditions
– prevention trials to test new ways to prevent disease including medicines, vaccines, vitamins, or changes to diet, lifestyle or behaviour
Clinical trials in Australia need to be efficiently administrated and resourced with qualified healthcare professionals as well as suitable patients.
Shanny Dyer, CEO ARCS Australia talks about a recent summit where the CRO (Contract Research Organization) community was asked on the current state of clinical trials in Australia. Commentary from:
– Tanya Symons, Director at T Symons Associates
– Daniela Caiazza, Director Clinical Operations ANZ, Novotech CRO
– Adam Stoneley, Research Operations Manager, Icon Cancer Centre
– Gabrielle McKee, Chief Operating Officer, CNS Clinical Network
– Joe Taouk, Senior Director Research and Development, IQVIA
#AustralianHealthJournal #ClinicalTrials
-
Australian Healthcare and Hospitals Association (AHHA) Blueprint Refresh Roundtable
AHHA’s Blueprint Refresh Roundtable brings together AHHA members and other Australian health leaders to evaluate the progress made to date against Healthy people, healthy systems and to tease out key policy issues that need to be addressed in order to implement outcomes-focused, value-based care in Australia.
-
Caring for community
With a passion for helping people, Carina Fernandes in her final year at Western Sydney University received accolades as a nursing student. Now a recent graduate, having completed her Bachelor of Nursing (Advanced) degree, and recognised as an Emerging Nurse Leader 2021 by the Australian College of Nursing, Carina has her sights set on her new role in healthcare, at the same time keeping sustainability top of mind.
-
Research funded to investigate early-onset bowel cancer progression
Bowel Cancer Australia recently announced a team led by Professor Michael Samuel as the successful applicant for a three-year $600k early-onset bowel cancer research project through the 2023 round of Cancer Australia’s Priority-driven Collaborative Cancer Research Scheme (PdCCRS).
